SARS-CoV-2, the virus that causes COVID-19, likely does not directly infect the brain but can still inflict significant neurological damage, according to a new study
Middle-age and older people living in more disadvantaged neighbourhoods — areas with higher poverty levels and fewer educational and employment opportunities — had more brain
Treating people with Type 2 diabetes with a new once-a-week injectable insulin therapy proved to be safe and as effective as daily insulin injections, according
Telehealth has become a critical way for doctors to still provide health care while minimizing in-person contact during COVID-19. But with phone or Zoom appointments,
Childhood disability is not a priority in health systems. A recently published article in the BMJ by Cieza and colleagues argues why this needs to
Continuing with a strong focus on staff wellbeing, DB Results has announced it will follow New Zealand’s landmark legislation by offering bereavement leave to staff,
A new study using human genetics suggests researchers should prioritize clinical trials of drugs that target two proteins to manage COVID-19 in its early stages.
The World Health Organization’s new Global Diabetes Compact aims to bring a much-needed boost to efforts to prevent diabetes and bring treatment to all who
The Young Onset Parkinson’s Exchange app (YOP-X) is an Australian-first digital platform that aims to provide critical support to young Aussies affected by the disease.
Disruption to HIV treatment as high as 75% has been reported in some countries—to prevent increased AIDS-related deaths, HIV services must continue during the COVID-19
Procter and Gamble (P&G) have announced the approval and closing deal of its acquisition of Australia’s leading effervescent vitamin brand, VOOST, for an undisclosed sum.
Read the opinion piece by Australian Government Chief Medical officer, Professor Paul Kelly. Throughout the COVID-19 pandemic, the highest priority in our response has been